Brief: Microport Neurotech Says Numen Coil Embolization System Approved For Commercialization In Japan
26/08/2022 14:58
Aug 26 (Reuters) - MicroPort NeuroTech Ltd 2172.HK :
* NUMEN COIL EMBOLIZATION SYSTEM APPROVED FOR
COMMERCIALIZATION IN
JAPAN
Further company coverage: 2172.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MicroPort NeuroScientific
See all newsBrief: MicroPort NeuroScientific Corp Says Artemis Dream Enters NMPA Green Path
Brief: Microport Neuroscientific To Continue Share Repurchases Up To Hkd100 Million
Brief: Microport Neuroscientific Says FDA Approves Numentm Helia Coil For Marketing
Brief: Microport Neuroscientific Posts FY Profit Attributable Rmb184.5 Million
Brief: Microport Neuroscientific Says FDA Grants Breakthrough Device Designation To Apollo Dream Rapamycin Stent System